UPDATE : Friday, August 17, 2018
상단여백
Panagene wins patent for molecular diagnostic platform
Panagene said Thursday that it has completed its patent registration for PA...
by Lee Han-soo  |  2017-12-01 11:02
라인
Medipost hits record vial sales for Cartistem
Medipost said Thursday that it hit record sales of 266 vials for Cartistem,...
by Lee Han-soo  |  2017-11-30 16:16
라인
Biopharmaceutical firms' liver treatments draw attention
Local biopharmaceutical companies, including Sillajen, HLB, and Pharmicell,...
by So Jae-hyeon  |  2017-11-30 12:02
라인
What are doctors’ views on Invossa used even by foreign patients?
An increasing number of patients here are trying to obtain Invossa-K, an os...
by Lee Hye-seon  |  2017-11-29 09:31
라인
Green Cross, Feldan start joint tech development
Green Cross Labcell and Feldan Therapeutics, a Canadian biotechnology compa...
by Lee Han-soo  |  2017-11-27 16:59
라인
Foreigners dump Medytox, Hugel; buy Celltrion, ViroMed
On Korea’s secondary stock market, foreign investors net bought the shares ...
by Nam Doo-hyun  |  2017-11-27 13:13
라인
Biogen Korea taps new CEO
Biogen Korea, the Korean branch of the American multinational biotech Bioge...
by Marian Chu  |  2017-11-27 11:57
라인
Clinical trials on CAR-T cell therapies surge in two years
The number of clinical trials on CAR-T (chimeric antigen receptor T-cell) t...
by Nam Doo-hyun  |  2017-11-24 15:53
라인
Kolon okayed for clinical trial to expand treatment for Invossa-K injection
The Ministry of Food and Drug Safety (MFDS) has approved Kolon Life Science...
by Lee Han-soo  |  2017-11-23 15:53
라인
GemVax & KAEL confirms potential tracer effective to reperfusion injury
A study conducted by the Seoul National University has confirmed that GV100...
by Constance Williams  |  2017-11-22 15:51
라인
COGIB spotlights future of innovative biotherapeutic
The Coordinating Center for Global Innovative Biotherapeutics (COGIB) analy...
by Lee Han-soo  |  2017-11-22 11:06
라인
KAEL confirms potential tracer as treatment for kidney cancer
GemVax & KAEL said a research article that confirms the potential of GV1001...
by Constance Williams  |  2017-11-20 15:44
라인
Samsung Bioepis wins European sales approval for Ontruzant
The European Commission (EC) has granted marketing authorization for Samsun...
by Lee Han-soo  |  2017-11-20 10:48
라인
ViroMed aims phase 1 trial on CAR-T cell therapy by 2020-2022
ViroMed said it would conduct a phase 1 clinical trial on CAR-T (chimeric a...
by Nam Doo-hyun  |  2017-11-17 13:53
라인
Earthquake hits biopharmaceutical factories in Pohang
With a magnitude 5.4 quake hitting Pohang in North Gyeongsang Province, ind...
by Nam Doo-hyun  |  2017-11-16 15:55
라인
J&J struggles to maintain market dominance of Remicade
Johnson & Johnson's (J&J) is going all out to maintain the dominance of...
by Lee Han-soo and Nam Doo-hyun  |  2017-11-16 10:25
라인
Hugel merges with subsidiaries
Hugel said Wednesday that it would merge with its subsidiaries, Hugel Pharm...
by Lee Han-soo  |  2017-11-15 17:51
라인
Macrogen reaffirms diagnostic sequencing capability with CAP certification
Macrogen, a local biotechnology company, announced Wednesday that it has ac...
by Constance Williams  |  2017-11-15 14:48
라인
Janssen drops suit against Samsung Bioepis on Renflexis
Samsung Bioepis said Tuesday that Janssen, a pharmaceutical company of John...
by Lee Han-soo  |  2017-11-14 17:59
라인
Celltrion to test combo therapy of new flu antibody drug, Tamiflu
Celltrion said it plans to launch a clinical trial on a combination therapy...
by Lee Hye-seon  |  2017-11-14 11:38
여백
여백
여백
Back to Top